PUBLISHER: The Business Research Company | PRODUCT CODE: 1945405
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945405
Intracranial stents are tubular devices placed inside blood vessels, canals, or ducts, primarily used for treating intracranial stenosis and brain aneurysms by opening blocked arteries.
The primary types of intracranial stents include self-expanding stents, balloon-expanding stents, and stent-assisted coil embolization. Self-expanding stents expand autonomously after insertion into the intended lumen, such as a blood vessel or organ. Balloon-expanding stents, also known as balloon-expandable stents, offer higher radial stiffness and more precise placement, designed to address restenosis in the iliac artery by opening clogged arteries and restoring blood flow. Stent-assisted coil embolization plays a role in stabilizing coils within an aneurysm, providing support for coil deposition while preventing coil herniation into the parent vessel lumen. These intracranial stents are applied in the treatment of conditions such as brain aneurysms and intracranial stenosis, and find utilization in various sectors including hospitals, ambulatory surgery centers, and others.
Tariffs are influencing the intracranial stents market by increasing costs of imported nitinol alloys, polymer coatings, precision manufacturing equipment, and neurointerventional accessories. Neurovascular treatment centers in North America and Europe are most affected due to dependence on imported high-specification stents, while Asia-Pacific faces cost pressures on device manufacturing and distribution. These tariffs are increasing procedure costs and limiting rapid adoption of newer devices. However, they are also promoting domestic stent manufacturing, regional sourcing of materials, and innovation in cost-efficient neurovascular implants.
The intracranial stents market research report is one of a series of new reports from The Business Research Company that provides intracranial stents market statistics, including intracranial stents industry global market size, regional shares, competitors with a intracranial stents market share, detailed intracranial stents market segments, market trends and opportunities, and any further data you may need to thrive in the intracranial stents industry. This intracranial stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The intracranial stents market size has grown rapidly in recent years. It will grow from $0.54 billion in 2025 to $0.63 billion in 2026 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to increasing incidence of intracranial aneurysms, rising prevalence of cerebrovascular diseases, improvements in endovascular treatment techniques, expansion of neurology specialty care centers, growing adoption of minimally invasive neurointerventions.
The intracranial stents market size is expected to see rapid growth in the next few years. It will grow to $1.13 billion in 2030 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to increasing demand for advanced neurovascular devices, rising focus on early stroke intervention, expansion of precision neurology treatments, growing investments in neurovascular R&D, increasing use of next-generation stent technologies. Major trends in the forecast period include increasing adoption of neurovascular stenting procedures, rising use of stent-assisted coil embolization, growing demand for biodegradable stent materials, expansion of advanced neuroimaging-guided interventions, enhanced focus on stroke and aneurysm management.
The anticipated rise in the incidence of brain aneurysms is poised to drive the growth of the intracranial stents market in the coming years. Characterized by the development of a bulge in the blood vessels of the brain, a brain aneurysm poses the risk of rupture, leading to brain hemorrhage and potential fatality. Intracranial vessel stenting (IVS) emerges as a minimally invasive treatment for addressing serious cerebral artery stenosis, a condition involving the weakening of arteries delivering blood to the brain. Reports indicate that approximately 3.2% of individuals worldwide have unruptured aneurysms, underscoring the significance of the increasing incidence of brain aneurysms in driving the growth of the intracranial stents market.
Major companies operating in the intracranial stents market are introducing new products such as the Pegasus HPC stent system to improve profitability and market positioning. The Pegasus HPC stent system is a medical device designed for patients with intracranial aneurysms and intracranial atherosclerotic disease (ICAD), enabling endovascular repair of the vessel neck and intracranial arteries. For example, in June 2023, Fluid Biomed, a Canada-based medical device company, carried out the first human implantation of its ReSolv polymer-metal hybrid flow-diverting stent for the treatment of intracranial aneurysms. According to the company, the device integrates a bioabsorbable polymer scaffold with a metal framework, delivering structural support while promoting vessel healing. This development marks a significant technological advancement in the intracranial stents market, as it is intended to lower long-term implant burden and enhance patient outcomes compared with conventional permanent stents.
In October 2024, Grand Pharmaceutical Group Limited, a China-based pharmaceutical and medical device company, partnered with Nanjing Kainite Medical Technology Co., Ltd. to jointly develop an adjustable intracranial stent retriever product named "Luci." With this partnership, the companies aim to advance stroke intervention technologies and strengthen their presence in the neurovascular device market. Nanjing Kainite Medical Technology Co., Ltd. is a China-based medical technology company specializing in the research and development of innovative neurointerventional devices.
Major companies operating in the intracranial stents market are Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Abbott Laboratories, Terumo Corporation, Balt Extrusion, Acandis GmbH, Phenox GmbH, Rapid Medical Ltd, Penumbra Inc, MicroPort Scientific Corporation, Johnson & Johnson, Cook Medical LLC, Biotronik SE & Co KG, Cardionovum GmbH, InspireMD Inc, Admedes Schuessler GmbH, Kaneka Corporation, W L Gore & Associates Inc, Cerebral Stents
North America was the largest region in the intracranial stents market in 2025. Asia-Pacific is expected to be the fastest region in the intracranial stents market share during the forecast period. The regions covered in the intracranial stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the intracranial stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The intracranial stents market consists of sales of Neuroform stents, Solitaire, Enterprise, and Leo plus, and Wingspan stent. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Intracranial Stents Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses intracranial stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for intracranial stents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intracranial stents market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.